4 most recent filings and news items mentioning AIM. Updated every 60 seconds.
RegulatoryJun 10, 2026Neutral
AIM ImmunoTech Inc. amended its bylaws effective June 9, 2026, modifying Section 1.9 of Article I to clarify voting procedures, proxy rules, and the voting standard for director elections and stockholder proposals. The amendment standardizes voting requirements to a plurality for
View filing at SEC.gov →
BiotechJun 5, 2026Neutral
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
View filing at SEC.gov →
OtherJun 4, 2026Positive
AIM ImmunoTech released a virtual investor video discussing Ampligen's potential application in treating Bundibugyo Ebola virus disease, highlighting preclinical research showing 100% protective survival in mouse models. The company emphasizes the unmet medical need for targeted
View filing at SEC.gov →
OfferingMay 21, 2026Neutral
AIM ImmunoTech Inc. filed an exhibit detailing the terms of Class I Common Stock Purchase Warrants, which are unregistered securities exercisable after stockholder approval. The warrants include standard anti-dilution provisions and define exercise mechanics tied to various tradi
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.